针对线粒体的阿苏酸-莱因合物:链接器调节的细胞透性,血系亲和性和抗癌活性
Dan-Dan Wang1, Li He2, Ming-Hui Qi1
1Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, 430072, China.
European journal of medicinal chemistry
|November 30, 2024
概括
这项研究通过将其与线粒体向的rhein (R) 联系起来,增强了素 (ART) 的抗癌活性. 最佳的结合物改善ART-heme相互作用,促进瘤抑制和诱导免疫细胞死亡.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 癌症研究 癌症研究
背景情况:
- 线粒体中的血红素是艺术素 (ART) 抗癌活性的标.
- 目前的ART策略专注于交付,忽视了ART-heme相互作用.
- 优化ART-heme相互作用对于增强抗癌疗效至关重要.
研究的目的:
- 开发一种新的策略,结合线粒体向和左边介导的形状调制来增强ART的抗癌活性.
- 为了研究不同链接剂对ART-heme相互作用和合体构成的影响.
- 评估优化结合物的体外和体内抗癌疗效和免疫原效应.
主要方法:
- 通过使用各种链接剂,将美素 (ART) 与素 (R) 结合在一起.
- 计算分析以预测合体构造和对和Fe离子的结合亲和力.
- 在体外和体内研究,以评估瘤抑制能力.
- 免疫性细胞死亡诱导的评估.
主要成果:
- 最佳的C4链接器结合体显示出有利的构造,增强的细胞透性,以及对和Fe离子的最高结合亲和力.
- 与传统方法相比,结合剂在体外和体内表现出优异的瘤抑制.
- 该战略克服了与TPP+向药物相关的快速清除的局限性.
- 结合剂诱导免疫细胞死亡,表明免疫疗法的潜力.
结论:
- 一种新型的药物结合体系统协同作用于线粒体向和链接介导的形状调制,以增强ART抗癌活性.
- 通过特定链接器结合优化ART-heme相互作用是癌症治疗的一个有希望的策略.
- 开发的结合物显示出克服耐药性和增强免疫治疗结果的潜力.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
09:12Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
6.9K
相关概念视频
01:46Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K